Application no. and date | 13786186.0 (espacenet) (Federated) (European Patent Register), 20131011 | Patent/reg. no. and date | DK/EP 2906251, 20170927 | Publication date | 20150819 | Priority no. and date | US 201261712928 P, 20121012, US 201261712924 P, 20121012, US 201361794922 P, 20130315, US 201361794954 P, 20130315, US 201361794997 P, 20130315 | EP pub. no. and date |
EP 2906251 20150819 | Effective date | | Applicant/owner | Medimmune Limited, Milstein Building Granta Park Cambridge, Cambridgeshire CB21 6GH, GB, ADC Therapeutics SA, route de la Corniche 3B
1066 Epalinges, CH | Applicant ref. no. | P81704070DK00E | Inventor | HOWARD, Philip Wilson, Spirogen Limited The QMB Innovation Centre 42 New Road
London Greater London E1 2AX, GB, VAN BERKEL, Patricius Hendrikus Cornelis, ADC Therapeutics SÃ rl Rue Saint-Pierre 2 C/O Michael Forer
1003 Lausanne, CH | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/551 (2006.01) , A61K 39/395 (2006.01) , A61K 47/68 (2017.01) , A61P 35/02 (2006.01) , C07K 16/28 (2006.01) , C07K 16/30 (2006.01) | Title | Pyrrolobenzodiazepin-anti-CD22-antistofkonjugater | Int. application no. | EP2013071352 | Int. publication no. | WO2014057122 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|